Cell Reports Medicine SCIE
國際簡稱：Cell Rep Med 參考譯名：細胞醫(yī)學報道
主要研究方向：Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all) 非預警期刊 審稿周期：約Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks
《細胞醫(yī)學報道》(Cell Reports Medicine)是一本由Elsevier出版的以Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)為研究特色的國際期刊，發(fā)表該領域相關的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領域相關理論、實踐和應用學科的最新發(fā)現，旨在促進該學科領域科學信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預警名單。該期刊享有很高的科學聲譽，影響因子不斷增加，發(fā)行量也同樣高。
- 1區(qū) 中科院分區(qū)
- Q1 JCR分區(qū)
- 305 年發(fā)文量
- 11.7 IF影響因子
- 開放 是否OA
- 2020 創(chuàng)刊年份
- Monthly 出版周期
- English 出版語言
Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.
The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.
Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.
The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.
Cell Reports Medicine期刊信息
- ISSN：2666-3791
- 出版語言：English
- 是否OA：開放
- E-ISSN：2666-3791
- 出版地區(qū)：United States
- 是否預警：否
- 出版商：Elsevier
- 出版周期：Monthly
- 創(chuàng)刊時間：2020
- 開源占比：0.8876
- Gold OA文章占比：93.57%
- OA被引用占比：
- 出版國人文章占比：0
- 出版撤稿占比：
- 研究類文章占比：95.74%
Cell Reports Medicine CiteScore評價數據（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指數 | ||||||||||||
| 15 | 4.276 | 1.664 |
|
名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據是期刊最近4年（含計算年度）的被引次數除以該期刊近四年發(fā)表的文獻數。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數量÷2019-2022年發(fā)布的文獻數量 注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數據論文。
Cell Reports Medicine中科院評價數據
中科院 2023年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 1區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 CELL BIOLOGY 細胞生物學 | 1區(qū) 2區(qū) |
中科院 2022年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 1區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 CELL BIOLOGY 細胞生物學 | 1區(qū) 2區(qū) |
Cell Reports Medicine JCR評價數據（2023-2024年最新版）
| 按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：CELL BIOLOGY | SCIE | Q1 | 22 / 205 |
89.5% |
| 學科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 10 / 189 |
95% |
| 按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：CELL BIOLOGY | SCIE | Q1 | 14 / 205 |
93.41% |
| 學科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 8 / 189 |
96.03% |
Cell Reports Medicine歷年數據統(tǒng)計
影響因子
中科院分區(qū)
Cell Reports Medicine中國學者發(fā)文選摘
-
1、Current understanding of the intratumoral microbiome in various tumors
Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100884
-
2、Inherited mutations in Chinese patients with upper tract urothelial carcinoma
Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100883
-
3、Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100881
-
4、Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100934
-
5、Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Author: Wang, Han-Min; Zhang, Chan-Yuan; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Li, Yu-Fa; Li, Wen-Feng; Gao, Qing-Yun; Zhang, Shi-Ling; Chen, Yu-Qing; Zhou, Qing; Xu, Cong; Xu, Chong-Rui; Wang, Zhen; Su, Jian; Yan, Hong-Hong; Zhang, Xu-Chao; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100911
-
6、Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
Author: Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100859
-
7、Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
Author: Tang, Zhaoqing; Gu, Yuan; Shi, Zhongyi; Min, Lingqiang; Zhang, Ziwei; Zhou, Peng; Luo, Rongkui; Wang, Yan; Cui, Yuehong; Sun, Yihong; Wang, Xuefei
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100931
-
8、DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence
Author: Liu, Lixue; Wu, Xiaohang; Lin, Duoru; Zhao, Lanqin; Li, Mingyuan; Yun, Dongyuan; Lin, Zhenzhe; Pang, Jianyu; Li, Longhui; Wu, Yuxuan; Lai, Weiyi; Xiao, Wei; Shang, Yuanjun; Feng, Weibo; Tan, Xiao; Li, Qiang; Liu, Shenzhen; Lin, Xinxin; Sun, Jiaxin; Zhao, Yiqi; Yang, Ximei; Ye, Qinying; Zhong, Yuesi; Huang, Xi; He, Yuan; Fu, Ziwei; Xiang, Yi; Zhang, Li; Zhao, Mingwei; Qu, Jinfeng; Xu, Fan; Lu, Peng; Li, Jianqiao; Xu, Fabao; Wei, Wenbin; Dong, Li; Dai, Guangzheng; He, Xingru; Yan, Wentao; Zhu, Qiaolin; Lu, Linna; Zhang, Jiaying; Zhou, Wei; Meng, Xiangda; Li, Shiying; Shen, Mei; Jiang, Qin; Chen, Nan; Zhou, Xingtao; Li, Meiyan; Wang, Yan; Zou, Haohan; Zhong, Hua; Yang, Wenyan; Shou, Wulin; Zhong, Xingwu; Yang, Zhenduo; Ding, Lin; Hu, Yongcheng; Tan, Gang; He, Wanji; Zhao, Xin; Chen, Yuzhong; Liu, Yizhi; Lin, Haotian
Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100912
Cell Reports Medicine同類期刊
-
公共衛(wèi)生前沿
Frontiers In Public Health
中科院 3區(qū) JCR Q2
-
藥理學前沿
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
-
生物醫(yī)學與藥物治療
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
-
探索腫瘤學
Discover Oncology
中科院 4區(qū) JCR Q2
-
Bmc精神病學
Bmc Psychiatry
中科院 2區(qū) JCR Q2
-
Bmc神經病學
Bmc Neurology
中科院 3區(qū) JCR Q3
-
材料化學雜志 B
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
-
美康
Medcomm
中科院 3區(qū) JCR Q1
免責聲明
若用戶需要出版服務，請聯(lián)系出版商：ELSEVIER, RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX。